Dignitana Signs Agreement with ION Solutions

Dignitana AB today announces an agreement with ION Solutions (ION), a part of AmerisourceBergen, to easily provide DigniCap to oncology practices that are members of the ION Group Purchasing Organization (GPO). The DigniCap® Scalp Cooling System minimizes hair loss from chemotherapy in patients with solid tumors.

Files for download
Dignitana Release - wkr0006.pdf

ION Solutions is the largest physician service organization and group purchasing organization specializing in the support of community oncology practices. Approximately half of the private practice oncologists in the U.S. from over 1,100 medical practices utilize GPO services from ION. The company is dedicated to offering providers the tools necessary to maintain the highest quality patient care available.

“ION strives to improve patients' lives by delivering innovative products and services that drive quality and efficiency in medical care“ said Nicole Chambers, Corporate Account Director at ION Solutions. “DigniCap is a natural extension to the services that we provide to members. We know this is something patients and doctors want, and the ION GPO offers a streamlined contracting process with the added benefit of negotiated volume pricing.”

“Several of our current customers are members of ION, and the strength of those relationships has paved the way for this significant agreement,” said William Cronin, Chief Executive Officer of Dignitana AB.  “ION shares our commitment to enhancing quality of life for cancer patients while providing operational efficiencies to medical practices. This agreement with ION is an important part of Dignitana’s ongoing effort to make scalp cooling a standard of care in the United States.”

Dignitana is the world leader in scalp cooling innovation providing the DigniCap Scalp Cooling System in 30 states in the U.S. and 40 countries around the globe.

For More Information Contact 

Melissa Bourestom, VP Corporate Communications melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB, +46 8 121 576 90, certifiedadviser@redeye.se and www.redeye.seLearn more at www.dignitana.se and www.dignicap.com.